Healionics raises $4.7M to commercialize artificial blood vessel tech
The STARgraft vascular graft from Healionics acts as an artificial blood vessel for dialysis patients. (Healionics Photo) New financing: Seattle-based medical device company Healionics raised a $ 4.7 million round in a round led by Keiretsu Capital to help commercialize its STARgraft artificial blood vessel for patients undergoing dialysis treatment. Patients with kidney failure may … Read more